Table 2.

Detail of cervical and anal samples from HIV positive patients with squamous intraepithelial lesions and HPV DNA negative or positive for HPV types that are not included in nonavalent vaccine.

		N. of cases (%) Pt HPV- 9v Neg	N. of cases (%) Pt HPV DNA Neg
Cervical samples	LSIL (n = 231)	72 (31.2)	70 (30.3)
	HSIL (n = 55)	17 (30.9)	6 (10.9)
Anal samples	AIN 1 (n = 18)	9 (50)	3 (16.7)
	AIN 2 (n = 7)	5 (71.4)	0
	AIN 3 (n = 1)	1	0

Pt, patient; LSIL, Low Grade Squamous Intraepithelial Lesion; HSIL, High Grade Squamous Intraepithelial Lesion; AIN, Anal intraepithelial neoplasia; 9v, nonavalent vaccine. These data are partially presented in CME event “Novità nel campo dell'infezione da HPV,” Rome, 20th June 2018 INMI L Spallanzani IRCCS.